Updated:
Grönemeyer Health
Grönemeyer Health invests growth capital in Swiss and German healthcare companies, led by Till Grönemeyer with a 16-company portfolio in Digital Health…
Grönemeyer Health
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Switzerland
City
Zurich
Corporate office
Stockerstrasse 42, CH-8002 Zurich, Switzerland
Principals
Professor Dr. Dietrich Grönemeyer
Founder
Till Grönemeyer
Head of Investments
Dr. Sibylle Peter
President of the Board of Directors
Sector focus
Frequently asked questions
Who runs investment decisions at Grönemeyer Health?
Till Grönemeyer, son of founder Professor Dr. Dietrich Grönemeyer, has managed the investment portfolio across all asset classes for the Grönemeyer group for 12 years. Dr. Sibylle Peter, founder of YSMA AG and a former private banking executive, serves as President of the Board. Professor Grönemeyer guides the firm's strategic healthcare philosophy.
How does Grönemeyer Health source proprietary deal flow?
The firm leverages Professor Grönemeyer's network as a practicing physician, author, and media figure in German healthcare. It also draws on operating relationships from its own clinics and distribution activities, creating direct access to healthcare startups and growth companies in German-speaking markets.
Is Grönemeyer Health structured as a single family office or does it operate more like a venture firm?
It is structured as a private asset management company (Grönemeyer Swiss Health AG) that invests family capital across venture, growth, and direct operating businesses. It also acts as a distributor of healthcare products, combining investment with operational revenue.
Does Grönemeyer Health participate in fund commitments or only direct deals?
The firm primarily makes direct investments in portfolio companies and also operates its own distribution business. It does not disclose fund-of-funds or third-party LP commitments. The Grönemeyer group has previously launched a sustainable healthcare fund, the 'Grönemeyer Gesundheitsfond nachhaltig'.
What investment stages does Grönemeyer Health typically target?
The firm targets growth and venture-stage healthcare companies. It invests across a spectrum from high-tech medical devices to digital health and natural medicine products.
Which sectors does Grönemeyer Health explicitly avoid?
The firm focuses exclusively on healthcare and health-related sectors. It does not disclose explicit exclusions but concentrates on HealthCare, MedTech, HealthTech, Digital Health, and Health-Consumables, with no disclosed activity outside health.
Where does the underlying wealth come from?
The wealth originates from Professor Dr. Dietrich Grönemeyer's medical practice as a radiologist, his founding of microtherapy and the Grönemeyer Institute for Microtherapy chain, authoring bestselling health books, and his media presence including a ZDF television series.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: